Navigation Links
Codexis Board Elects Pedro I. Mizutani, Raizen EVP, as Director
Date:7/28/2011

REDWOOD CITY, Calif., July 28, 2011 /PRNewswire/ -- Codexis, Inc. (Nasdaq: CDXS) today announced that Pedro I. Mizutani, Executive Vice President, Upstream Business, Raizen Energia Participacoes S.A, has been elected to the Codexis Board of Directors. Mr. Mizutani serves as the Board representative of Raizen, Brazil's largest sugar and ethanol producer. Raizen holds approximately 16% of Codexis' outstanding shares of common stock and is the company's largest stockholder.

"We are delighted to have Pedro Mizutani join our Board," said Alan Shaw, Ph.D., President and Chief Executive Officer. "He brings a wealth of executive experience in industrial, financial and agricultural operations, as well as an in-depth knowledge of the Brazilian fuels and sugar markets. Mr. Mizutani is widely known and respected in the Brazilian business community, and his deep industry knowledge and strategic counsel will bring immediate value to Codexis."

Mr. Mizutani joined Raizen in June 2011 and has responsibility for all upstream business (production of sugar, ethanol, and bioenergy). From 2000-2010, he was Director at Cosan Group with responsibility for all upstream production, and in 2010 was appointed CEO of Cosan Sugar and Ethanol. Cosan is one of the largest groups in Brazil, with businesses in energy, food, logistics, infrastructure and agricultural property management.

He holds a degree in production engineering from the University of Sao Paulo, an MBA from the Getulio Vargas Foundation and a post-graduate degree in finance from the Methodist University of Piracicaba. He has also attended extension courses in business management at Ohio University and the Kellogg School of Management at Northwestern University. Mr. Mizutani is a member of the Board of Directors of Cosan Group, UNICA, the Brazilian sugar trade association, and Centro de Tecnologia Canavieria, a sugarcane research center in Brazil.

Codexis is a clean technology company. Codexis develops optimized biocatalysts that make industrial processes faster, cleaner and more efficient. Codexis' technology is commercialized with leading global pharmaceutical companies and in development for advanced biofuels with shell and carbon capture. Other potential markets for the company's biocatalyst-enabled solutions include chemicals and water treatment. For more information, see www.codexis.com.

Contacts:
Media: Lyn Christenson, lyn.christenson@codexis.com, 650.421.8144 or Saskia Sidenfaden, ssidenfaden@mww.com, 212.827.3771 Investors: Henk Adriaenssens, ir@codexis.com, 650.421.8331


'/>"/>
SOURCE Codexis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Codexis Reports Second Quarter 2011 Results
2. Codexis and Chemtex to Collaborate on Sustainable Detergent Alcohols for the Household Products Market
3. Codexis to Present at the Pacific Crest and Canaccord Genuity Conferences
4. Codexis to Present at 3 Investor Conferences in June
5. Codexis Achieves Development Milestones With Teva
6. Codexis to Present at Barclays Conference
7. Codexis to Announce First Quarter 2011 Financial Results on May 5, 2011
8. Codexis Names Jacques Beaudry-Losique VP Corporate Development & Strategy
9. Codexis Announces Carbon Capture Progress at ARPA-E Summit
10. Codexis Names David Anton CTO & SVP, Process Development & Manufacturing
11. Codexis to Present at the Jefferies and Pacific Crest Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... PLEASANTON, Calif. , May 23, 2017 /PRNewswire/ ... world,s most innovative medical devices for pressure ulcer ... at the American Association of Critical Care Nurses, ... Houston May 22-25. The Leaf Patient ... designed specifically for the hospital environment.  The system ...
(Date:5/22/2017)... MAITLAND, Fla. , May 22, 2017 /PRNewswire/ ... industry as a whole continue to make the ... evidence becomes increasingly important for ensuring positive patient ... Key industry stakeholders are shifting focus away from ... results and effects of long-term specialty drug therapy ...
(Date:5/18/2017)... 17, 2017  Bayer announced today that the latest ... presented at the 53 rd Annual Meeting of ... June 2-6 in Chicago . ... prostate, colorectal, liver and thyroid cancers, as well as ... II CHRONOS-1 trial of copanlisib in patients with relapsed ...
Breaking Medicine Technology:
(Date:6/26/2017)... , ... June 26, 2017 , ... Torrance dentist, Dr. ... can be one of the most noticeable aspects of a person’s appearance. A healthy, ... everyone is born with beautiful, balanced teeth, everyone can have the smile of their ...
(Date:6/26/2017)... ... 26, 2017 , ... The Centers for Advanced Orthopaedics (The ... Richard Robinson as chief operating officer (COO). In this role, Robinson brings more ... record of simplifying business processes and developing growth strategies to increase market share. ...
(Date:6/26/2017)... ... 26, 2017 , ... LARKR™ , an innovative new smartphone app providing ... the country to join its online treatment platform. , Launching in just a ... substantially greater number of people in need nationwide, and to supplement their traditional practices. ...
(Date:6/26/2017)... ... June 26, 2017 , ... New patients with missing teeth ... or without a referral. Dr. Cotey is a trusted dentist who has placed many ... option. , Patients with missing teeth in Fitchburg, WI, are encouraged to find out ...
(Date:6/25/2017)... ... June 25, 2017 , ... Republicans in the United States Senate ... called the Better Care Reconciliation Act. It differs significantly from the American Health Care ... be reconciled in committee, or the House will have to take up the Senate ...
Breaking Medicine News(10 mins):